| Test Code | Test Name | U.S. Patent No. |
| 871 | BBS1 (BBS) DNA Sequencing Test | 6,962,788 |
| 872 | BBS2 (BBS) DNA Sequencing Test | 7,008,782, 6,962,788 |
| 827 | ABCC8 (CH) DNA Sequencing Test | 6,054,313 |
| 876 | ABCC8 (NDM) DNA Sequencing Test | 6,054,313 |
| 483 | AChR/MuSK Reflexive Antibody Test | 7,267,820, 7,732,147 |
| 179 | ADmark® Early Onset Alzheimer's Evaluation | 6,117,978 6,194,153, 6,531,586 6,210,919, 6,998,467, 6,485,911, 5,840,540, 5,986,054, 7,846,679, 7,838,247 |
| 167 | ADmark® PS-1 DNA Sequencing Test | 6,194,153, 6,210,919, 6,531,586, 6,998,467 |
| 169 | ADmark® PS-2 DNA Sequencing Test | 6,485,911, 6,117,978, 5,840,540, 7,838,247 |
| 178 | ADmark® Alzheimer's Evaluation | 5,843,779, 5,861,257 6,010,913 6,114,133 |
| 177 | ADmark® Phospho-Tau/Total-Tau/Ab42 CSF Analysis & Interpretation (Symptomatic) | 5,843,779, 5,861,257, 6,010,913, 6,114,133 |
| 493 | Aprataxin DNA Sequencing Test | 7,119,186, 7,824,860 |
| 352 | Ataxia-Telangiectasia (ATM) DNA Deletion Analysis | 5,955,279, 6,951,724, 6,458,536 |
| 351 | Ataxia-Telangiectasia (ATM) DNA Sequencing Analysis | 5,955,279, 6,951,724, 6,458,536 |
| 531 | Atlastin (SPG3A) DNA Sequencing Test | 7,649,088, 7,108,975, 7,582,425 |
| 812 | Autoimmune Polyglandular Syndrome (AIRE) Evaluation | 7,217,806, 7,785,789 |
| 697 | Autosomal Dominant Ataxia Evaluation | 5,741,645, 5,840,491, 5,853,995, 6,303,307, 6,280,938, 6,514,755, 6,524,791, 6,673,535, 6,844,431, 6,855,497, 7,118,893, 7,329,487, 7,585,629, 7,655,401, 7,741,458, 8,247,173, 8,748,096, 8,975,018, 8,163,483 |
| 653 | Autosomal Dominant Hereditary Spastic Paraplegia Evaluation | 6,924,126, 7,108,975, 7,582,425, 7,811,762, 7,649,088 |
| 693 | Autosomal Recessive Ataxia Evaluation | 7,824,860, 7,119,186 |
| 887 | Bardet-Biedl Syndrome Evaluation | 7,008,782, 6,962,788, 7,947,479, 8,129,161 |
| 837 | CEL (MODY8) Mutation Analysis | 5,827,683 |
| 277 | Co-GM1 Quattro™ | 5,989,829, 5,985,578, 6,077,681, 6,824,999, 6,020,140 |
| 861 | COL1A1 (OI) DNA Sequencing Test | 6,265,157 |
| 696 | Complete Ataxia Evaluation | 5,741,645, 5,840,491, 5,853,995, 6,150,091, 6,303,307, 6,280,938, 6,514,755, 6,524,791, 6,844,431, 6,673,535, 6,855,497, 7,118,893, 7,119,186, 7,329,487, 7,527,931, 7,585,629, 7,655,401, 7,824,860, 8,163,483 |
| 353 | Complete Ataxia-Telangiectasia (ATM) Evaluation | 5,955,279, 6,951,724 |
| 286 | Complete Dejerine Sottas Neuropathy | 5,786,927, 727,698, 7,537,899 |
| 655 | Complete Hereditary Spastic Paraplegia Evaluation | 6,924,126, 7,108,975, 7,582,425, 7,811,762 |
| 243 | Complete HNPP Evaluation | 5,780,223, 5,599,920, 5,306,616 |
| 147 | Complete Myotonia Evaluation | 5,955,265, 5,977,333, 6,902,896, 7,442,782 |
| 126 | Complete Myotonic Dystrophy Evaluation | 5,955,265, 5,977,333 |
| 761 | Complete PKD Evaluation | 6,228,591, 6,031,088, 7,294,465, 7,553,644, 6,916,619, 7,521,190, 7,273,701, 7,083,915, 8,530,161 |
| 153 | Complete Rett Syndrome Evaluation | 6,709,817, 7,670,773, 8,637,236 |
| 573 | Complete SCN1A Evaluation | 7,078,515 |
| 215 | Complete SMA Evaluation (Reflexive) | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
| 556 | Complete Tuberous Sclerosis Evaluation | 6,326,483, 6,232,452, 6,548,258 |
| 819 | Congenital Hyperinsulinism Evaluation | 6,054,313, 5,723,593 |
| 245 | Congenital Hypomyelination Evaluation | 5,876,927 |
| 329 | Connexin Related Deafness Evaluation | 5,998,147, 6,485,908, 7,258,975, 8,455,195, 8,143,000 |
| 133 | Connexin32 DNA Sequencing Test | 5,691,144, 6,001,576 |
| 143 | Connexin32 Evaluation | 5,691,144, 6,001,576 |
| 674 | CSTB (EPM1) Evaluation | 6,432,635 |
| 321 | Cx26 DNA Sequencing Test | 5,998,147, 6,485,908, 7,258,975, 8,455,195, 8,143,000 |
| 108 | DM1 DNA Test | 5,955,265, 5,977,333 |
| 110 | DM2 DNA Test | 6,902,896, 7,442,782 |
| 561 | Dysferlin Protein Blood Test | 7,172,858 |
| 626 | Dystonia (DYT1) DNA Test | 6,387,616, 6,921,814 |
| 207 | Early Onset Myotonia Evaluation | 5,955,265, 5,977,333 |
| 722 | Early Onset Nephrotic Syndrome Evaluation | 7,105,291, 6,207,811, 6,924,110, 7,388,086, 7,799,529 |
| 881 | Endocrine Hypertension (HSD11B2) Evaluation | 5,883,240, 5,780,223 |
| 296 | Entrapment Neuropathy Evaluation | 5,780,223 |
| 187 | Familial Hemiplegic Migraine Type I (CACNA1A) DNA Test | 5,714,319 |
| 119 | Friedreich Ataxia DNA Test | 6,150,091 |
| 348 | Friedreich's Ataxia DNA Sequencing Analysis | 6,150,091 |
| 349 | Friedreich's Ataxia Profile | 6,150,091 |
| 770 | Hereditary Interstitial Kidney Disease Assay | 7,781,164, 8,759,001 |
| 802 | HNF4A (MODY1) DNA Sequencing and Deletion Test | 6,187,533 |
| 717 | Inherited Focal and Segmental Glomerulosclerosis (FSGS) Evaluation | 6,924,110, 7,388,086, 7,745,597 |
| 874 | Lipoid CAH (StAR) Evaluation | 5,807,678, 5,872,230 |
| 222 | LITAF/SIMPLE DNA Sequencing Test | 7,449,291 |
| 811 | LRP5 (OPPG) DNA Sequencing Test | 6,545,137, 6,555,654, 7,244,577 |
| 821 | LRP5 Idiopathic Osteoporosis (IOP) DNA Sequencing Test | 6,545,137, 6,555,654, 7244,577 |
| 543 | LRRK2 DNA Test | 7,544,786, 7,993,841 |
| 145 | MAG 'Dual Antigen'® Autoantibody Test | 6,599,756, 6,951,763 |
| 223 | MFN2 DNA Sequencing Test | 7,727,717, 8,206,922, 8,975,020 |
| 885 | Monogenic Diabetes (MODY) Evaluation | 5,827,683, 6,187,533, 6,274,310 |
| 346 | Motor Neuropathy Profile - Complete | 6,599,756 6,951,763 , 5,807,705, 6,020,140 6,077,681, 6,824,999 |
| 482 | MuSK Antibody Test | 7,267,820, 7,732,147 |
| 134 | Myelin Protein Zero (MPZ) DNA Sequencing Test | 5,876,927 |
| 438 | NeoCerebellar Degeneration Paraneoplastic Profile with Recombx | 7,329,499, 5,925,526, 5,807,705, 6,387,639, 7,026,450 |
| 4620 | NeoComplete Paraneoplastic Profile with Recombx | 7,329,499, 5,925,526, 5,807,705, 6,387,639 7,026,450 |
| 4722 | NeoEncephalitis Paraneoplastic Profile with Recombx | 7,329,499, 5,807,705, 6,387,639, 7,026,450 |
| 882 | Neonatal Diabetes Mellitus Evaluation | 6,054,313, 5,863,724 |
| 360 | NeoSeM® Basic Paraneoplastic Profile | 5,925,526, 5,807,705 |
| 436 | NeoSensory Neuropathy Paraneoplastic Profile with Recombx™ | 7,329,499, 5,807,705 |
| 532 | NIPA1 (SPG6) DNA Sequencing Test | 7,332,282, 8,518,638 |
| 846 | Noonan Syndrome (PTPN11) DNA Sequencing Test | 7,335,469 |
| 421 | Notch3 DNA Sequencing Test | 7,138,234 |
| 730 | NPHS1 (Nephrin) Sequencing Analysis | 7,799,529, 7,105,291, 6,207,811 |
| 710 | NPHS2 (Podocin) Sequencing Analysis | 6,924,110, 7,388,086 |
| 300 | OPMD DNA Test | 6,828,430, 7,364,852 |
| 239 | Periaxin DNA Sequencing Test | 7,273,698, 7,537,899 |
| 889 | Pheochromocytoma Evaluation | 6,312,890, 5759,790 |
| 728 | PKDx® Familial Mutation Evaluation | 6,656,681, 6,228,591, 6,031,088, 7,294,465, 6,485,960, 6,916,619, 7,273,701, 7,083,915, 7,553,644, 7,521,190, 8,530,161 |
| 725 | PKDx® Sequencing Analysis | 6,656,681, 6,228,591, 6,031,088, 7,294,465, 6,485,960, 7,553,644, 6,916,619, 7,521,190, 7,273,701, 7,083,915, 7,553,644, 7,521,190, 8,530,161 |
| 247 | PMP22 DNA Sequencing Test | 5,780,223 |
| 131 | PMP22 Duplication/Deletion DNA Test | 5,780,223 |
| 816 | Primary Adrenal Insufficiency Evaluation | 7,217,806, 5,869,039, 7,785,789 |
| 639 | Primary Dystonia Evaluation | 6,387,616, 6,921,814 |
| 122 | Recombx™ MaTa Autoantibody Test | 6,387,639, 7,026,450 |
| 123 | Recombx™ CV2 Antibody Test | 7,329,499, 7,183,400 |
| 120 | Recombx™ Hu Autoantibody Test | 5,807,705 |
| 125 | Recombx™ Yo Autoantibody Test | 5,925,526 |
| 529 | REEP1 (SPG31) DNA Sequencing Test | 7,811,762 |
| 142 | Rett Syndrome (MECP2) DNA Sequencing Test | 6,709,817, 7,670,773, 8,637,236 |
| 148 | Rett Syndrome (MECP2) Duplication/Deletion Analysis | 6,709,817, 7,670,773, 8,637,236 |
| 371 | SCA1 DNA Test | 5,834,183, 5,741,645 |
| 387 | SCA10 DNA Test | 6,855,497 |
| 284 | SCA13 Select Exon DNA Test | 7,585,629, 8,163,483 |
| 593 | SCA14 DNA Test | 7,655,401 |
| 672 | SCA2 Expansion Analysis | 6,673,535, 6,844,431, 8,957,018 |
| 105 | SCA3 (Machado-Joseph Disease) DNA Test | 5,840,491 |
| 675 | SCA5 DNA Sequencing Test | 7,527,931 |
| 373 | SCA6 DNA Test | 7,329,487 |
| 677 | SCA7 Expansion Analysis | 6,280,938, 6,514,755, 7,118,893 |
| 384 | SCA8 DNA Test | 6,524,791, 7,741,458, 8,748,096, 8,247,173 |
| 537 | SCN1A Deletion Test | 7,723,027, 8,288,096 |
| 287 | SensoriMotor Neuropathy Profile-Complete | 6,599,756 6,951,763 , 5,807,705, 5,985,578, 6,020,140, 6,824,999 |
| 265 | Sensory Neuropathy Profile | 6,599,756, 6,951,763 5,807,705, 6,020,140, 5,985,578 |
| 263 | Sensory Neuropathy Profile-xp | 6,599,756, 6,951,763 , 5,807,705, 6,020,140, 5,985,578 |
| 594 | SETX DNA Sequencing Test | 7,704,691, 8,192,933 |
| 214 | SMA Plus (Reflexive) | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
| 211 | SMN DNA Sequencing Test | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
| 530 | Spastin (SPG4) DNA Sequencing Test | 6,924,126 |
| 444 | Spinal Muscular Atrophy Carrier Test | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
| 111D | Spinal Muscular Atrophy Diagnostic Test | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
| 210 | Sulfatide Autoantibody Test | 6,020,140, 5,985,578 |
| 804 | TCF1 (MODY3) DNA Sequencing and Deletion Test | 6,187,533 |
| 805 | TCF2 (MODY5) DNA Sequencing and Deletion Test | 6,187,533 |
| 712 | TRPC6 DNA Sequencing Test | 7,745,597 |
| 523 | TSC Familial Mutation Evaluation | 6,326,483, 6,232,452 |
| 508 | TSC1 Deletion Analysis | 6,548,258 |
| 521 | TSC1 DNA Sequencing Test | 6,326,483, 6,548,258 |
| 524 | TSC2 DNA Deletion Test | 6,232,452 |
| 522 | TSC2 DNA Sequencing Test | 6,232,452 |
| 858 | von Hippel Lindau VHL | 5,759,790 |